{
    "2021-06-28": [
        [
            {
                "time": "",
                "original_text": "百克IPO急扩产品，单款疫苗扛九成收入，市场天花板见顶，自研太慢或开启收购",
                "features": {
                    "keywords": [
                        "百克IPO",
                        "扩产",
                        "疫苗",
                        "九成收入",
                        "市场见顶",
                        "自研",
                        "收购"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}